Compounds > palladium
Page last updated: 2024-08-22

palladium and 5,10,15,20-tetrakis(4-methoxyphenyl)porphyrin

palladium has been researched along with 5,10,15,20-tetrakis(4-methoxyphenyl)porphyrin in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Banerjee, S; Chakraborty, S; Das, T; Sarma, HD1

Other Studies

1 other study(ies) available for palladium and 5,10,15,20-tetrakis(4-methoxyphenyl)porphyrin

ArticleYear
109Pd labeled 5,10,15,20-tetrakis[4-carboxymethyleneoxyphenyl]porphyrin: a potential agent for targeted tumor therapy.
    Current radiopharmaceuticals, 2012, Volume: 5, Issue:4

    Topics: Animals; Drug Stability; Female; Fibrosarcoma; Mice; Molecular Targeted Therapy; Neoplasm Transplantation; Palladium; Porphyrins; Radioisotopes; Radiopharmaceuticals; Transplantation, Heterologous

2012